Is the traditional Chinese medicine helpful for patients with hematologic malignant diseases? A meta-analysis of randomized controlled trials

doi:10.13105/wjma.v3.i3.163

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9620)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-27) series.

Item

Count

PDF

432

WORD

326

HTML

3460

Figures (1-7)

137

Tables (1-27)

183

Sum=4538

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

465

Download

1981

Sum=2446

Publishing Process of This Article

Item

Count

Browse

1067

Download

1569

Sum=2636

Jun 26, 2015 (publication date) through Jun 10, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Meta-Anal. Jun 26, 2015; 3(3): 163-180
Published online Jun 26, 2015. doi: 10.13105/wjma.v3.i3.163

Table 5 Characteristics of Xiu Mei 1997 study

Methods	A randomized controlled study
Participants	Non-Hodgkin lymphoma patients
Interventions	TCM group: Standard chemotherapy + traditional Chinese medicine
	Control group: Standard chemotherapy
Outcomes	The primary outcome: The overall response rate

TCM: Traditional Chinese medicine.

Citation: Qian CL, Yan F, Song YZ, Li D, Dong KZ, Zhu YM. Is the traditional Chinese medicine helpful for patients with hematologic malignant diseases? A meta-analysis of randomized controlled trials. World J Meta-Anal 2015; 3(3): 163-180
URL: https://www.wjgnet.com/2308-3840/full/v3/i3/163.htm
DOI: https://dx.doi.org/10.13105/wjma.v3.i3.163